Skip to main content
OpenTrials

Clinical trial condition

Ocular Hypertension

Explore clinical trials studying Ocular Hypertension. Study availability and eligibility vary by location and protocol.

440 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Ocular Hypertension trial results

Completed

A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom

NCT00751049

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +2 more
Locations
  • Pfizer Investigational Site Aberdeen, Grampian, United Kingdom
  • Pfizer Investigational Site Nottingham, Notts., United Kingdom
  • Pfizer Investigational Site Bristol, United Kingdom
  • Pfizer Investigational Site Cambridge, United Kingdom
View Trial Details
Completed

Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

NCT00334750

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +1 more
Locations
  • Pfizer Investigational Site Calgary, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Edmonton, Alberta, Canada
  • Pfizer Investigational Site Nanaimo, British Columbia, Canada
View all 21 locations
View Trial Details
Completed

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US

NCT00847483

Conditions
Eye Diseases, Glaucoma, Ocular Hypertension
Locations
  • Pfizer Investigational Site Bellflower, California, United States
  • Pfizer Investigational Site Inglewood, California, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site San Diego, California, United States
View all 40 locations
View Trial Details
Completed

SYL040012, Treatment for Open Angle Glaucoma

NCT02250612

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +2 more
Locations
  • Sall Research Medical Center Artesia, California, United States
  • North Bay Eye Associates Petaluma, California, United States
  • Eye Care Centers Management, Inc (Clayton Eye Center) Morrow, Georgia, United States
  • Taustin Eye Center Louisville, Kentucky, United States
View all 21 locations
View Trial Details
Completed

Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension

NCT00846989

Conditions
Eye Diseases, Glaucoma, Glaucoma, Open-Angle, +1 more
Locations
  • Novartis Investigative Site Artesia, California, United States
  • Novartis Investigative Site Inglewood, California, United States
  • Novartis Investigative Site La Jolla, California, United States
  • Novartis Investigative Site Poway, California, United States
View all 29 locations
View Trial Details

Related conditions